Characterization of the L-arginine-NO-cGMP pathway in spontaneously hypertensive rat platelets: The effects of pregnancy

Hypertension Research

Volumn 33, Issue 9, 2010, Pages 899-904

  Resende, Ângela De Castro ^a   Ognibene, Dayane Teixeira ^a   Moss, Monique Bandeira ^a   Matsuura, Cristiane ^a   Brunini, Tatiana M ^a   De Moura, Roberto Soares ^a   Mendes Ribeiro, Antônio Cláudio ^a  

^a STATE UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

blood platelets; cyclic GMP; nitric oxide; pregnancy

Indexed keywords

ADENOSINE DIPHOSPHATE; ARGININE; CYCLIC GMP; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GUANYLATE CYCLASE; INDUCIBLE NITRIC OXIDE SYNTHASE; NITRIC OXIDE; PHOSPHODIESTERASE V;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD PRESSURE; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; ENDOTHELIAL DYSFUNCTION; ENZYME ACTIVITY; FEMALE; HYPERTENSION; NONHUMAN; PREGNANCY; PROTEIN EXPRESSION; RAT; SPONTANEOUSLY HYPERTENSIVE RAT; THROMBOCYTE; THROMBOCYTE AGGREGATION; THROMBOCYTE FUNCTION;

ANIMALS; ARGININE; BLOOD PLATELETS; CYCLIC GMP; CYCLIC NUCLEOTIDE PHOSPHODIESTERASES, TYPE 5; FEMALE; GUANYLATE CYCLASE; HYPERTENSION; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; NITRIC OXIDE SYNTHASE TYPE III; PLATELET AGGREGATION; PREGNANCY; RATS; RATS, INBRED SHR; RATS, WISTAR;

EID: 77956405691     PISSN: 09169636     EISSN: 13484214     Source Type: Journal    
DOI: 10.1038/hr.2010.102     Document Type: Article

References (51)

1. Sibai BM. Chronic hypertension in pregnancy. Obstet Gynecol 2002; 100: 369-377.
2. Fernandez CL, Carbajo RM, Munoz RM. Intrauterine growth restriction in spontaneously hypertensive rats. Hypertens Pregnancy 2004; 23: 275-283.
3. Poli KA, ToflerGH, Larson MG, Evans JC, Sutherland PA, Lipinska I, Mittleman MA, Muller JE, D'Agostino RB, Wilson PW, Levy D. Association of blood pressure with fibrinolytic potential in the framingham offspring population. Circulation 2000; 101: 264-269.
4. Kakar P, Lip GY. Hypertension: endothelial dysfunction, the prothrombotic state and antithrombotic therapy. Expert Rev Cardiovasc Ther 2007; 5: 441-450.
5. Moncada S, Higgs EA. Nitric oxide and the vascular endothelium. Handb Exp Pharmacol 2006; 176: 213-254.
6. Brunini TM, Mendes-Ribeiro AC, Ellory JC, Mann GE. Platelet nitric oxide synthesis in uremia and malnutrition: a role for L-arginine supplementation in vascular protection? Cardiovasc Res 2007; 73: 359-367.
7. Mullershausen F, Friebe A, Feil R, Thompson WJ, Hofmann F, Koesling D. Direct activation of PDE5 by cGMP: long term effects within NO-cGMP signaling. J Cell Biol 2003; 160:719-727.
8. Brunini T, Moss M, Siqueira M, Meirelles L, Rozentul A, Mann G, Ellory J, Soares de Moura R, Mendes-Ribeiro A. Inhibition of l-arginine transport in platelets by asymmetric dimethylarginine and N-monomethyl-l-arginine: effects of arterial hypertension. Clin Exp Pharmacol Physiol 2004; 31: 738-740.
9. de Meirelles LR, Mendes-Ribeiro AC, Mendes MA, da Silva MN, Ellory JC, Mann GE, Brunini TM. Chronic exercise reduces platelet activation in hypertension: upregulation of the l-arginine-nitric oxide pathway. Scand J Med Sci Sports 2009; 19: 67-74.
10. Moss MB, Brunini TM, Soares De Moura R, Novaes Malagris LE, Roberts NB, Ellory JC, Mann GE, Mendes Ribeiro AC. Diminished l-arginine bioavailability in hypertension. Clin Sci (Lond) 2004; 107: 391-397.
11. Queen LR, Xu B, Horinouchi K, Fisher I, Ferro A. Beta(2)-adrenoceptors activate nitric oxide synthase in human platelets. Circ Res 2000; 87: 39-44.
12. Radomski MW, Palmer RM, Moncada S. An l-arginine/nitric oxide pathway present in human platelets regulates aggregation. Proc Natl Acad Sci USA 1990; 87: 5193-5197.
13. Freedman JE, Loscalzo J, Barnard MR, Alpert C, Keaney JF, Michelson AD. Nitric oxide released from activated platelets inhibits platelet recruitment. J Clin Invest 1997; 100: 350-356.
14. Chung AW, Radomski A, Alonso-Escolano D, Jurasz P, Stewart MW, Malinski T, Radomski MW. Platelet-leukocyte aggregation induced by par agonists: regulation by nitric oxide and matrix metalloproteinases. Br J Pharmacol 2004; 143: 845-855.
15. Racasan S, Braam B, Koomans HA, Joles JA. Programming blood pressure in adult SHR by shifting perinatal balance of NO and reactive oxygen species toward NO: the inverted barker phenomenon. Am J Physiol Renal Physiol 2005; 288: F626-F636.
16. Iacono A, Bianco G, Mattace Raso G, Esposito E, d'Emmanuele di Villa Bianca R, Sorrentino R, Cuzzocrea S, Calignano A, Autore G, Meli R. Maternal adaptation in pregnant hypertensive rats: improvement of vascular and inflammatory variables and oxidative damage in the kidney. Am J Hypertens 2009; 22: 777-783.
17. Paller MS. Mechanism of decreased pressor responsiveness to ANG II, NE, and vasopressin in pregnant rats. Am J Physiol 1984; 247: H100-H108.
18. Coelho EB, Ballejo G, Salgado MC. Nitric oxide blunts sympathetic response of pregnant normotensive and hypertensive rat arteries. Hypertension 1997; 30: 585-588.
19. Ballejo G, Barbosa TA, Coelho EB, Antoniali C, Salgado MC. Pregnancy-associated increase in rat systemic arteries endothelial nitric oxide production diminishes vasoconstrictor but does not enhance vasodilator responses. Life Sci 2002; 70: 3131-3142.
20. Ware JA, Heistad DD. Seminars in medicine of the Beth Israel Hospital, Boston. Platelet-endothelium interactions. N Engl J Med 1993; 328: 628-635.
21. Resende AC, Pimentel AML, Soares de Moura R. Captopril reverses the reduced vasodilator response to bradykinin in hypertensive pregnant rats. Clin Exp Pharmacol Physiol 2004; 31: 756-761.
22. Knock GA, Poston L. Bradykinin-mediated relaxation of isolated maternal resistance arteries in normal pregnancy and preeclampsia. Am J Obstet Gynecol 1996; 175: 1668-1674.
23. Ashworth JR, Baker PN, Warren AY, Johnson JR. Mechanisms of endothelium-depen- dent relaxation in myometrial resistance vessels and their alteration in preeclampsia. Hypertens Pregnancy 1999; 18: 57-71.
24. Gilham JC, Kenny LC, Baker PN. An overview of endothelium-derived hyperpolarizing factor (EDHF) in normal and compromised pregnancies. Eur J Obstet Gynecol Reprod Biol 2003; 109: 2-7.
25. Luscher TF. Platelet-vessel wall interation: role of nitric oxide, prostaglandins and endothelins. Baillieres Clin Haematol 1993; 6: 609-627.
26. Radomski MW, Moncada S. Regulation of vascular homeostasis by nitric oxide. Thromb Haemost 1993; 70: 36-41. (Pubitemid 23225447)
27. Mendes Ribeiro AC, Brunini TM, Yaqoob M, Aronson JK, Mann GE, Ellory JC. Identification of system y+L as the high-affinity transporter for L-arginine in human platelets: up-regulation of L-arginine influx in uraemia. Ptlugers Arch 1999; 438: 573-575.
28. Morris HR, Morris HR, Etienne AT, Panico M, Tippins JR, Alaghband-Zadeh J, Holland SM, Mehdizadeh S, de Belleroche J, Das I, Khan NS, de Wardener HE. Hypothalamic hypertensive factor: an inhibitor of nitric oxide synthase activity. Hypertension 1997; 30: 1493-1498. (Pubitemid 27528094)
29. O'Kane P, Xie L, Liu Z, Queen L, Jackson G, Ji Y, Ferro A. Aspirin acetylates nitric oxide synthase type 3 in platelets thereby increasing its activity. Cardiovasc Res 2009; 83: 123-130.
30. Burkhardt M, Glazova M, Gambaryan S, Vollkommer T, Butt E, Bader B, Heermeier K, Lincoln TM, Walter U, Palmetshofer A. KT5823 inhibits cGMP-dependent protein kinase activity in vitro but not in intact human platelets and rat mesangial cells. J Biol Chem 2000; 275: 33536-33541.
31. Halvey EJ, Vernon J, Roy B, Garthwaite J. Mechanisms of activity-dependent plasticity in cellular nitric oxide-cGMP signaling. J Biol Chem 2009; 284: 25630-25641.
32. Paul W, Queen LR, Page CP, Ferro A. Increased platelet aggregation in vivo in the Zucker Diabetic Fatty rat: differences from the streptozotocin diabetic rat. Br J Pharmacol 2007; 150: 105-111.
33. Deves R, Chavez P, Boyd CA. Identification of a new transport system (y+L) in human erythrocytes that recognizes lysine and leucine with high affinity. J Physiol 1992; 454: 491-501.
34. Brosnihan KB, Neves LAA, Anton L, Joyner J, Valdes G, Merril DC. Enhanced expression of Ang-(1-7) during pregnancy. BrazJ Med Biol 2004; 37: 1255-1262.
35. Norris LA, Higgins JR, Darling MR, Walshe JJ, Bonnar J. Nitric oxide in the uteropla- cental, fetoplacental, and peripheral circulations in preeclampsia. Obstet Gynecol 1999; 93: 958-963.
36. Kim YJ, Park HS, Lee HY, Ha EH, Suh SH, Oh SK, Yoo HS. Reduced l-arginine level and decreased placental eNOS activity in preeclampsia. Placenta 2006; 27: 438-444.
37. Moncada S, Higgs A. The L-arginine-nitric oxide pathway. N Engl J Med 1993; 329: 2002-2012.
38. Deves R, Boyd CA. Transporters for cationic amino acids in animal cells: discovery, structure, and function. Physiol Rev 1998; 78: 487-545.
39. Reshef R, Schwartz D, Ingbir M, Shtabsky A, Chernichovski T, Isserlin BA, Chernin G, Levo Y, Schwartz IF. A profound decrease in maternal arginine uptake provokes endothelial nitration in the pregnant rat. Am J Physiol Heart Circ Physiol 2008; 294: H1156-H1163.
40. Goumas G, Tentolouris C, Tousoulis D, Stefanadis C, Toutouzas P. Therapeutic modification of the l-arginine-eNOS pathway in cardiovascular diseases. Atherosclerosis 2001; 154: 255-267.
41. Myatt L. Review: reactive oxygen and nitrogen species and functional adaptation of the placenta. Placenta 2010; 31(Suppl): S66-S69.
42. Brune B, Ulrich V. Inhibition of platelet aggregation by carbon monoxide is mediated by activation of guanylate cyclase. Mol Pharmacol 1987; 32: 497-504.
43. Schmidt HHHW, Lohmann SM, Walter U. The nitric oxide and cGMP signal transduction system: regulation and mechanism of action. Biochimica et Biophysica Acta 1993; 1178: 153-175.
44. Presley T, Vedam K, Velayutham M, Zweier JL, Ilangovan G. Activation of HSP90-eNOS and increased no generation attenuate respiration of hypoxia-treated endothelial cells. Am J Physiol Cell Physiol 2008; 295: C1281-C1291.
45. Bender AT, Demady DR, Osawa Y. Ubiquitination of neuronal nitric-oxide synthase in vitro and in vivo. J Biol Chem 2000; 275: 17407-17411.
46. Musial A, Eissa NT. Inducible nitric-oxide synthase is regulated by the proteasome degradation pathway. J Biol Chem 2001; 276: 24268-24273.
47. Averna M, Stifanese R, De Tullio R, Salamino F, Bertuccio M, Pontremoli S, Melloni E. Proteolytic degradation of nitric oxide synthase isoforms by calpain is modulated by the expression levels of hsp90. FEBS J 2007; 274: 6116-6127.
48. Valdes G, Kaufmann P, Corthorn J, Erices R, Brosnihan KB, Joyner-Grantham J. Vasodilator factors in the systemic and local adaptations to pregnancy. Reprod Biol Endocrinol 2009; 7: 79.
49. Haslam RJ, Dickinson NT, Jang EK. Cyclic nucleotides and phosphodiesterases in platelets. Thromb Haemost 1999; 82: 412-423.
50. Vandecasteele G, Verde I, Rucker-Martin C, Donzeau-Gouge P, Fischmeister R. Cyclic GMP regulation of the l-type Ca(2+) channel current in human atrial myocytes. J Physiol 2001; 533: 329-340.
51. Riba R, Patel B, Aburima A, Naseem KM. Globular adiponectin increases cGMP formation in blood platelets independently of nitric oxide. J Thromb Haemost 2008; 6: 2121-2131.